6W. Eiermann,S. Paepke,J. Appfelstaedt,A. Llombart-Cussac,J. Eremin,J. Vinholes,L. Mauriac,M. Ellis,M. Lassus,H. A. Chaudri-Ross,M. Dugan,M. Borgs,V. Semiglazov. Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study[J] 2001,Annals of Oncology(11):1527～1532
6[2]Henderson C,Berry DA,Demetri GD,et a1.Improved outcomes from adding sequential paelitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.J Clin Oncol,2003,21(6):976～983
7[3]Steven D Heys,Tarun Sarkar,Andrew W Hutcheon,et al. Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer.Expert Opinion on Pharmacotherapy, 2004,5(10):2147～2157
8[4]Citron ML,Berry DA,Cirrineione C,et a1.Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 974l.J Clin Oncol,2003,21(8):1431～1439
9[9]Early Breast Cancer Trialists'Collaborative Group.Tamoxifen for early breast cancer:an overview of the randomized trials.Lancet,1998,351:1451
10[10]Coombes RC,Hall E,Gibson LJ,et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.N Engl J Med,2004,350:1081
